An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety and efficacy of three test article foams (PDI-192 0.1%
Foam, PDI-192 0.15% Foam, and Vehicle Foam) such that a final commercial product may be
selected for future development.